Business Wire

NY-ALVAREZ-&-MARSAL

Share
Alvarez & Marsal Announces 2023 Managing Director Promotions

Leading global professional services firm Alvarez & Marsal (A&M) has announced the promotion of 85 professionals across Brazil, Benelux, Canada, Cayman Islands, China, France, Germany, India, Spain, United Arab Emirates, United Kingdom and the United States, to the position of Managing Director.

Tony Alvarez II and Bryan Marsal, A&M’s Co-Founders, stated, “Congratulations to all our newly promoted Managing Directors. Their commitment to help clients maximize value and drive change amid ongoing macro-economic challenges builds upon our legacy of operational excellence while advancing our results-oriented mission. Their proven ability to help solve for clients’ complex problems is critical to the firm’s success and growth moving forward.”

Asia

Henry Chambers, Hong Kong

Eden Chen, Shanghai

Sally Sun, Hong Kong

Brazil

Pedro Bortolotto, São Paulo

Marcelo Compte, São Paulo

Rodrigo Domingues, São Paulo

Lilian Giorgi, São Paulo

Rodrigo Hong, São Paulo

Henrique Kanashiro, São Paulo

Rafael Mendonca Rodrigues, São Paulo

Fabio Missiato, São Paulo

Corporate Performance Improvement

Tiffany Guthrie, Houston

Mike Hall, San Francisco

John McKinnis, Dallas

Sam Rudkin, Atlanta

Consumer and Retail Group

Kenneth Cochran, Charlotte

Jeffrey Dwyer, Chicago

Lakshman Lakshmanan, Dallas

Chad Lusk, Chicago

Joanna Rangarajan, New York

Global Disputes and Investigations

Lee Betteridge, London

Gary Foster, London

EMEA – Performance Improvement

Private Equity Performance Improvement

Nicola Barbini, London

Chris Gobby, London

Britta Mittler, Frankfurt

Till Prinz, Dusseldorf

Tim Veen, Munich

Gerardo Villalba Bello, Madrid

Ysabel Gaspar Zayco, London

Financial Services Industry

Robert Bradbury, London

Dominic Roope, London

Corporate Transformation

Jatin Arora, Dubai

Mark Bennett, Paris

Daran Hopper, London

Dirk Naujokat, Munich

Steve Trainor, London

Diana Wong, London

EMEA Restructuring

Insolvency

Barry Lynch, Grand Cayman

Helen Skeates, London

Turnaround

David Johnston, London

José Miguel Gómez Rivas, Madrid

Middle East

Bill Ozturk, Dubai

Environmental, Social and Governance (ESG)

Stephanie Weiler, Chicago

Healthcare Industry Group

JoyAnn Book, Phoenix

Bianca A. Briola Charlotte

David Nidetz, Detroit

Rich Rieger, Chicago

India

Anup Gandhi, Mumbai

Pranav Sheth, Mumbai

Infrastructure & Capital Projects

Sue Frost, Washington, D.C.

Alan Richard, Washington, D.C.

Private Equity Performance Group

Kent Edgerton, Nashville

Jana Gold, Washington, D.C.

Brad Howard, New York

Larry Thomas, Tampa

Klaus Weisenberger, San Francisco

Public Sector

Daniel Harlan, Washington, D.C

Restructuring & Turnaround (North America)

Taylor Atwood, Dallas

Matthew Davidson, Detroit

Chad Ellison, Calgary

Kamila Khairoullina, New York

Mark Sidorenkov, Phoenix

Jeff Sielinski, Detroit

Michael Zembillas, Atlanta

Global Taxand

Simon Bernstein, New York

Stephanie Doughty, Houston

Michael Farkas, New York

Simon Gore, London

Jack Hollyman, London

Jac Emilio Martinez, Miami

Joseph Plati, New York

Brendan Sinnott, New York

Katya Umanskaya, Los Angeles

Global Transaction Advisory Group

Anuj Astir, New York

Nout Brugman, Amsterdam

David Cho, Chicago

Vitor Garcia, Sao Paulo

Jimmy Glenn, Atlanta

Nick Lynch, London

Jai Tandan, Mumbai

Rhett Taylor, Nashville

Nick Thoele, New York

Cedric Zana, Paris

Valuation Services

Cole Corbin, New York

Steven Fischoff, Chicago

About Alvarez & Marsal

Companies, investors and government entities around the world turn to Alvarez & Marsal (A&M) for leadership, action and results. Privately held since its founding in 1983, A&M is a leading global professional services firm that provides advisory, business performance improvement and turnaround management services. When conventional approaches are not enough to create transformation and drive change, clients seek our deep expertise and ability to deliver practical solutions to their unique problems.

With over 7,000 people across five continents, we deliver tangible results for corporates, boards, private equity firms, law firms and government agencies facing complex challenges. Our senior leaders, and their teams, leverage A&M’s restructuring heritage to help companies act decisively, catapult growth and accelerate results. We are experienced operators, world-class consultants, former regulators and industry authorities with a shared commitment to telling clients what’s really needed for turning change into a strategic business asset, managing risk and unlocking value at every stage of growth.

To learn more, visit: AlvarezandMarsal.com. Follow A&M on LinkedIn, Twitter, and Facebook.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230117005828/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

TreeFrog Therapeutics Presents Delivery Strategy for Next Generation 3D Cell Therapy Format for Parkinson’s Disease at the 28th Annual ASGCT Meeting in New Orleans13.5.2025 08:00:00 CEST | Press release

TreeFrog Therapeutics is the first company to present publicly a clinical-ready delivery strategy for 3D format microtissues in cell therapy.After four years in development, the validated device and delivery strategy overcomes challenges of 3D formats and uses existing stereotactic components to support adoption through ease of delivery education. TreeFrog Therapeutics, a French biotech specializing in cell therapy is the first company to present a clinical-ready delivery strategy for 3D microtissues cell therapy. The validated approach was demonstrated for their 3D neural microtissues cell therapy treatment for Parkinson’s disease. Parkinson’s disease is the second most common neurodegenerative disorder after Alzheimer’s disease. It is a progressive disease characterized by the loss of dopaminergic neurons with a mix of motor symptoms (bradykinesia, rigidity, resting tremor) and non-motor symptoms (cognitive deficits, mood disorders, fatigue). Current treatments provide symptomatic re

Ohana Development Launches ‘Jacob & Co. Beachfront Living by Ohana,’ A Masterpiece of Beachfront Elegance in the UAE13.5.2025 08:00:00 CEST | Press release

Valued at USD 1.3 billion, the project offers world-class amenities, including a signature Jacob & Co. ceiling art timepiece, the largest of its kind globally. Ohana Development, the leading real estate developer renowned for its luxury properties, has launched ‘Jacob & Co. Beachfront Living by Ohana’ in partnership with luxury timepiece and jewellery house Jacob & Co. The project was revealed at Emirates Palace Mandarin Oriental, Abu Dhabi. Located in Al Jurf between Dubai and Abu Dhabi, this USD 1.3 billion development blends natural surroundings with exceptional artistry and craftsmanship. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250512533615/en/ Jacob & Co. Beachfront Living by Ohana. (Photo: AETOSWire) Jacob & Co. Beachfront Living by Ohana presents 457 residences comprising of sea-view apartments, villas, penthouses, Sky Mansions, and beachfront mansions—each capturing the spirit of refined coastal living. Pentho

Azafaros Secures € 132M in Oversubscribed Series B Financing to Advance Phase 3 Clinical Programs of Innovative Therapies in Lysosomal Storage Disorders13.5.2025 07:00:00 CEST | Press release

Financing round led by Jeito Capital and co-led by Forbion Growth, with participation from Seroba, Pictet Group and other existing investorsProceeds to fund two Phase 3 pivotal programs with nizubaglustat, lead asset in Niemann-Pick disease Type C (NPC) and GM1/GM2 gangliosidoses as well as expanding the Azafaros pipeline to other indicationsNizubaglustat has been awarded Orphan Drug Designation in both the US and Europe as well as Fast-track status in the US. The company expects to initiate both Phase 3 studies later this year Azafaros, a clinical-stage company focused on developing disease-modifying therapeutics to offer new treatment options to patients with rare lysosomal storage disorders, announces the completion of an oversubscribed €132M Series B financing led by Jeito Capital, co-led by Forbion Growth and with additional participation from Seroba, Pictet Group and existing investors Forbion Ventures, Schroders Capital and BioGeneration Ventures (BGV). This financing enables Az

Presidio Investors is Pleased to Announce the Addition of Christian Schütte as Its Newest Operating Partner12.5.2025 19:04:00 CEST | Press release

Christian brings more than 20 years of global experience in investment banking, private equity, and operational leadership, with a proven track record of driving transformational growth across industries. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250512473756/en/ Christian Schütte Christian began his career at J.P. Morgan in New York and London, where he worked in the M&A and Corporate Finance teams. He later joined Fortress Investment Group and was instrumental in launching its German operations. During his tenure, he helped raise over €1.5 billion in equity and managed a wide array of investments, including non-performing and performing loans, private and public companies. He went on to join EQT Group, where he focused on mid-market growth and succession investments. Notably, he led the consolidation of nine digital marketing agencies into a €100 million market leader, building one of the most comprehensive digital ma

Introducing Joblio – The Future of Ethical Recruitment12.5.2025 18:30:00 CEST | Press release

Joblio Launches to Revolutionize Ethical Recruitment and End Worker Exploitation Joblio, a global ethical recruitment platform, officially launches today to tackle the broken labor migration system—long plagued by exploitative intermediaries, high recruitment fees, and human rights abuses. With its tech-driven model, Joblio connects vetted workers with employers directly, eliminating unethical middlemen and ensuring cost-free hiring for migrant workers. Employers fund access to talent, but workers never pay—a key step in ending exploitation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250512628048/en/ A Mission Rooted in Personal Experience Joblio is led by Jon Purizhansky, a refugee-turned-entrepreneur who experienced migration challenges firsthand. Forced to flee his home country as a young man, Jon faced the uncertainty and vulnerability that millions of migrant workers still encounter today. Now a globally recognized

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye